Corporate Disclosure
SILCOPHL Corporate Disclosure — 23 August 2020
SILCOPHL published a corporate disclosure on 23 August 2020. Read the full announcement for details.
SILCOPHLPharmaceuticals & Chemicals
Follow the latest news and corporate disclosures of Silco Pharmaceuticals Limited (DSE: SILCOPHL), including board meetings, quarterly financial results, dividend decisions, record dates, AGM notices and regulatory updates.
SILCOPHL published a corporate disclosure on 23 August 2020. Read the full announcement for details.
SILCOPHL published a corporate disclosure on 30 June 2020. Read the full announcement for details.
SILCOPHL will hold a board meeting on 29 June 2020 at 3:30 PM.
Brokers and merchant bankers were asked to stop providing margin-loan facilities for purchases of SILCOPHL shares from 3 February 2020.
SILCOPHL moved from N category to A category effective 3 February 2020 after reporting disbursement of its approved cash dividend.
SILCOPHL published a corporate disclosure on 2 February 2020. Read the full announcement for details.
SILCOPHL published a corporate disclosure on 2 February 2020. Read the full announcement for details.
SILCOPHL will hold a board meeting on 30 January 2020 at 3:30 PM.
SILCOPHL published a corporate disclosure on 25 November 2019. Read the full announcement for details.
SILCOPHL published a corporate disclosure on 19 November 2019. Read the full announcement for details.